Christoffer Johansen
@FessorC
Followers
153
Following
79
Media
13
Statuses
105
Jeg har arbejdet 30 år med kræft forskning og sidder på kræftafdelingen på RH som professor i senfølger efter kræft. En vild hund i det bedre kræft selskab
Copenhagen, Denmark
Joined June 2009
Editorial about changing cancer-follow-up is out! With @FessorC @BoletteRafn @signeborgquist Peer Christiansen @PeterCh12345 Bobby Zachariae @Helle_PP @ulassen
Follow-up for cancer is changing! We argue that follow-up should be patient-, not calendar-driven, and focus on late effects, not recurrence. Read our editorial in @actaoncol #survivorship #lateeffects @senfoelger
https://t.co/6Fx43pJHqO
0
1
3
Follow-up for cancer is changing! We argue that follow-up should be patient-, not calendar-driven, and focus on late effects, not recurrence. Read our editorial in @actaoncol #survivorship #lateeffects @senfoelger
https://t.co/6Fx43pJHqO
0
3
7
Sometimes @CASTLE_research actually learn and even enjoy learning - the two days at @DDA_Denmark. Together with colleagues from different backgrounds including @benteklarlundp and @signeborgquist it opened up for ideas. Thanks to organizers @LykkeSylow @LangLehrskov @TLaurberg
0
0
4
The Danish Diabetes Academy workshop onDiabetes and Metabolism - this time with a focus on cancer. BeingRoyal Danish Academy for Sciences and ...Letters (?) - our forefarthers are participating..
0
0
7
Enjoying day 1 of our first (hopefully of many) seminar on Cancer and Metabolism with fantastic speakers and poster teamwork by @EmmaFrank96 @SteffenRaun @Mona_ali1990 @DDA_Denmark @BiomedUCPH
0
3
40
Important update on evidence base and first(!) Danish clinical guidelines for monitoring and treatment of lymphedema after breast cancer with DBCG presented by @BoletteRafn at @Senfoelger late effects seminar today. PROTECTtrial funded by @trygfonden will inform guideline-update
0
3
10
De to hundrede deltagere siger velkommen til mit indlæg om @CASTLE_research - hvad laver vi og hvor er fremtiden. @DCCCcancer @cancer_dk #dkpol #sundpol
0
2
13
Now our road trip has a pit stop at Hindsgavl for a day on late effects. The CEO of the Danish Cancer Society is taking care of the opening
0
0
4
Opening of the European Cancer Rehabilitation Survivorship Symposium @FessorC @jesper_fisker @Marianne_nord1 @actaoncol @cancer_dk Exciting program and important focus on late effects over the next two days in Copenhagen! #ECRS2022
0
1
8
ECRS 2022 Copenhagen focusing on survivorship issues including interventions from screening to clinical follow-up, exercise, PROMs, rehabilitation and more.
0
3
11
A symposium focused on very important topics for #cancer manegement with a focus on patient health! We are very glad to participate and contribute. @cancer_dk @signebenzon #ECRS #ECRS2022
0
2
6
A great talk on #screening for #ProstateCancer by @auvinen_anssi during #ECRS. Pinpointing perfectly the pro's and con's of screening. My take-away: we need evidence on risk stratified and mri based screening before implementation. @cancer_dk
0
4
10
European Cancer Rehabilitation and Survivorship Symposium 2022 has started. Looking forward to learning a lot over the next 2 days. @cancer_dk #ECRS2022 @actaoncol @jesper_fisker @FessorC
0
1
4
Hvem er CASTLE og hvad forsker vi i? Vi fortsætter rækken af portrætter af forskerne på CASTLE. Læs med på Linkedin! Denne gang om @BoletteRafn
https://t.co/3qF3Ef8mA6
0
3
5
No observable impact of #CellPhone #MobilePhone📱 #EMF on #glioma incidence rates in Nordic countries according to new study by IARC researchers & partners. Article in @env_int_journal evaluates evolution of incidences rates in these countries in 1979-2016 https://t.co/mc4JaeRJM4
5
19
34